Kim et al. have built tumor-targeted lipid nanoparticles by combining EGF (epidermal growth factor) receptor (EGFR) aptamer–lipid conjugates and hydrophobic quantum dots responsible for target-cell recognition and fluorescence observation, respectively (Fig. 5B) [74]. The gene discussed is EGFR; the disease is neoplasm.